c009 fedratinib mce (MedChemExpress)
95
Structured Review
MedChemExpress
c009 fedratinib mce
C009 Fedratinib Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 58 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fedratinib/Fedratinib/pm42275215-230-184-186
Average 95 stars, based on 58 article reviews
C009 Fedratinib Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 58 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fedratinib/Fedratinib/pm42275215-230-184-186
Average 95 stars, based on 58 article reviews
c009 fedratinib mce - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Sterility:Article Title: Long noncoding RNA AFAP1-AS1 aggravates immunotherapy resistance in NSCLC by enhancing JAK2 and TYK2 translation. Article Snippet: Drug preparation: Anti-mouse PD-1 antibody (Selleck Chemicals, A2122, USA) was reconstituted in PBS according to the manufacturer’s instructions and administered intraperitoneally (i.p.) at 100 lg/mouse, three times weekly [23]. .. Saline:Article Title: Long noncoding RNA AFAP1-AS1 aggravates immunotherapy resistance in NSCLC by enhancing JAK2 and TYK2 translation. Article Snippet: Drug preparation: Anti-mouse PD-1 antibody (Selleck Chemicals, A2122, USA) was reconstituted in PBS according to the manufacturer’s instructions and administered intraperitoneally (i.p.) at 100 lg/mouse, three times weekly [23]. .. Injection:Article Title: Long noncoding RNA AFAP1-AS1 aggravates immunotherapy resistance in NSCLC by enhancing JAK2 and TYK2 translation. Article Snippet: Drug preparation: Anti-mouse PD-1 antibody (Selleck Chemicals, A2122, USA) was reconstituted in PBS according to the manufacturer’s instructions and administered intraperitoneally (i.p.) at 100 lg/mouse, three times weekly [23]. .. Recombinant:Article Title: Palmitoylation-mediated regulation of KAT2A promotes lung metastasis in breast cancer. Article Snippet: Acetylation is frequently dysregulated in cancer, and b ot h a ce ty lt ra ns ferase and deacetylase inhibitors are being evaluated at various stages of preclinical and clinical development.. However, how the expression of a c e ty l t ra n s ferases and deacetylases is regulated remains often elusive.. We focused on the lysine a c e ty l t ra n s ferase 2A (KAT2A) as it is important in multiple cancer indications with a clinical inhibitor in development. |